Sertraline is not directly associated with clinically significant nutrient deficiencies based on current evidence
The FDA drug label for sertraline does not list nutrient deficiencies as a recognized adverse effect 1. Clinical research examining routine blood chemistry values in 246 patients found no significant changes in electrolytes or other standard laboratory parameters with sertraline therapy 2. There is no established evidence that sertraline therapy causes specific vitamin or mineral deficiencies requiring routine monitoring.
What the Evidence Shows
Metabolic Effects (Not Nutrient Deficiencies)
Research has documented metabolic changes with sertraline, but these are distinct from nutrient deficiencies:
- Insulin and triglycerides: A prospective study found significantly increased insulin levels at 4,8, and 12 weeks of treatment, and elevated triglycerides at 8 and 12 weeks, though glucose and HbA1c remained unchanged 3
- Amino acid metabolism: Metabolomic studies show changes in branched-chain amino acids, TCA cycle intermediates, and fatty acid metabolism—these represent metabolic shifts rather than deficiencies 4
- Glutamate uptake: At therapeutic concentrations (3 μM), sertraline reduced platelet glutamate uptake by 28%, though this does not constitute a nutrient deficiency 5
Context from Other Medications
The evidence provided discusses nutrient deficiencies extensively in other clinical contexts—inflammatory bowel disease 6, bariatric surgery 7, 8, celiac disease 9, and Parkinson's disease 10—but none of these guidelines identify sertraline as causing nutrient deficiencies. In fact, sertraline appears in cholestatic liver disease guidelines as a fourth-line treatment for pruritus, with monitoring recommendations focused on fat-soluble vitamins due to cholestasis itself, not the medication 11.
Clinical Monitoring Recommendations
Standard monitoring for sertraline should focus on:
- Bleeding risk: Monitor for signs of bleeding when combined with NSAIDs, aspirin, or anticoagulants due to serotonin's effect on platelet function 1
- Prothrombin time: Check when initiating or stopping sertraline in patients on warfarin (8% mean increase observed) 1
- Sodium levels: While hyponatremia is a recognized SSRI side effect, the largest study (246 patients) found no significant sodium changes with sertraline 2
- Drug interactions: Monitor lithium levels, phenytoin concentrations, and valproate levels when co-prescribed 1
Special Populations
Pregnancy: A case report describes transient MADD-like biochemical patterns in newborns exposed to maternal sertraline, with elevated acylcarnitines that normalized by day 12 without intervention 12. This represents a transient metabolic effect rather than a nutrient deficiency requiring supplementation.
Common Pitfall
Do not confuse sertraline with medications that genuinely cause nutrient deficiencies (metformin causing B12 deficiency 13, or malabsorptive bariatric procedures causing multiple vitamin deficiencies 7, 8). The metabolic changes observed with sertraline—particularly insulin and triglyceride elevations—warrant cardiovascular risk monitoring but do not require vitamin or mineral supplementation 3.
No routine nutrient supplementation or specialized nutritional monitoring is indicated for patients taking sertraline based on current evidence.